The program provides financial support to 2 junior faculty researchers for a 2-year period. Each award is funded up to $130,000 (inclusive of any indirect costs), to be paid in annual installments of up to $65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report and approval by the Scientific Review Committee Chair.
Recipients of these competitive awards will be selected by the committee, comprised of leaders in thefields of cardiovascular disease, pulmonary arterial hypertension, HIV, liver disease, rheumatic autoimmune diseases, and inflammatory bowel disease. The committee will review complete applications and select research proposals based on their scientific merit, feasibility, and innovation. Announcement of award recipients will be made at an awards dinner hosted by the committee and senior representatives from Gilead Sciences.
Applicants must meet the eligibility criteria in order to be considered for an award.